Suchergebnisse - %22Drug Combinations%22

PubPharm (280)

1

Optimizing combination therapy in prostate cancer : mechanistic insights into the synergistic effects of Paclitaxel and Sulforaphane-induced apoptosis

enthalten in: BMC molecular and cell biology | 2024

von Habib, T. | Altonsy, M. | Ghanem, S. | +2

2

Synergistic inhibitory actions of resveratrol, epigallocatechin-3-gallate, and diallyl trisulfide against skin cancer cell line A431 through mitochondrial caspase dependent pathway : a combinational drug approach

enthalten in: Medical oncology (Northwood, London, England) | 2024

von Arumugam, G. | Alagar Yadav, S.

3

Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells

enthalten in: Journal of neuro-oncology | 2024

von Zeuner, S. | Vollmer, J. | Sigaud, R. | +7

4

Targeted Inhibition of Hsp90 in Combination with Metformin Modulates Programmed Cell Death Pathways in A549 Lung Cancer Cells

enthalten in: Applied biochemistry and biotechnology | 2023

von Hasan, A. | Khamjan, N. | Lohani, M. | +1

5

LCZ696 attenuates sepsis-induced liver dysfunction in rats; the role of oxidative stress, apoptosis, and JNK1/2-P38 signaling pathways

enthalten in: Life sciences | 2023

von Mohyeldin, R. | Alaaeldin, R. | Sharata, E. | +3

6

Shenmai injection ameliorates doxorubicin-induced myocardial injury by suppressing autophagy-apoptosis via miR-30a

enthalten in: Aging | 2023

von Li, Y. | Fan, L. | Wang, X. | +1

7

Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors

enthalten in: European journal of medicinal chemistry | 2023

von Tan, B. | Sacco, M. | Tan, H. | +5

8

A yeast-based system to study SARS-CoV-2 Mpro structure and to identify nirmatrelvir resistant mutations

enthalten in: PLoS pathogens | 2023

von Ou, J. | Lewandowski, E. | Hu, Y. | +12

UpdateOf: bioRxiv. 2022 Aug 08;:. - PMID 35982672

9

Integrative Approach to Dissect the Drug Resistance Mechanism of the H172Y Mutation of SARS-CoV-2 Main Protease

enthalten in: Journal of chemical information and modeling | 2023

von Clayton, J. | de Oliveira, V. | Ibrahim, M. | +5

UpdateOf: bioRxiv. 2023 Mar 06;:. - PMID 35982652

10

AI-Driven Discovery of SARS-CoV-2 Main Protease Fragment-like Inhibitors with Antiviral Activity In Vitro

enthalten in: Journal of chemical information and modeling | 2023

von Saramago, L. | Santana, M. | Gomes, B. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]